摘要
成人心脏有能力产生新的细胞,并在急慢性、缺血性和非缺血性心力衰竭显著增强。此外,许多血液传导祖细胞能够感应到心肌损害,并定位到损害位点从而进行心脏的修复。这个心肌生理学新观点导致不断增加的长期研究和心脏保护治疗为目标的研究开展。需要分析的一个基本概念是心脏疾病是否收特定组织的属性和循环祖细胞的变化的影响。失去自我更新能力、生长受损或死亡敏感性的增加可能导致祖细胞减少,让心肌留下未修复的损害。心脏祖细胞生成所有心肌细胞谱系,因而损害它们的增长,预计将严重损害心脏的结构和功能。事实上,除了众所周知的蒽环霉素的影响外,还有针对分子途径与细胞死亡和增长的新药物到导致的心脏毒性,可进一步支持我们的假设。了解心内和心外祖细胞的在不同的病因心肌病的发病机制的作用,不仅能更好地了解心脏内稳态,也将为治疗干预措施开辟新的途径。基于利用心肌和系统性心原性的细胞自我更新潜能的基础上,心肌的有效再生使有效的心脏保护和恢复心脏停搏成为可能。
关键词: 祖细胞,心肌保护,心脏毒性,缺血性心脏疾病,再生医学,干细胞
Current Drug Targets
Title:Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Volume: 16 Issue: 8
Author(s): Monia Savi, Federico Quaini, Antonella De Angelis, Francesco Rossi, Eugenio Quaini, Fancesca Re, Costanza Annamaria Lagrasta, Pietro Rossetti, Federica Galaverna, Francesca Ferraro, Konrad Urbanek, Lucia Prezioso, Andrea Gervasi, Bruno Lorusso, Stefano Cavalli, Angela Falco, Denise Madeddu, Gallia Graiani and Caterina Frati
Affiliation:
关键词: 祖细胞,心肌保护,心脏毒性,缺血性心脏疾病,再生医学,干细胞
摘要: The adult heart has the capacity to generate new myocytes that are markedly enhanced in acute and chronic heart failure of ischemic and non-ischemic origin. In addition, a pool of blood trafficking progenitor cells able to sense myocardial damage may home to the sites of injury participating to cardiac repair. This new view of myocardial biology leads to an expanding long-term research and therapeutic goals for cardioprotection. A fundamental concept to be analyzed is whether cardiac diseases are influenced by changes in the properties of tissue specific and circulating progenitors. Loss of self-renewal capacity, impaired growth or increased susceptibility to death may lead to a reduction of progenitors and leave myocardial damage unrepaired. Cardiac progenitors generate all myocardial cell lineages, thus impairment in their growth is expected to be critically involved in the structural and functional modifications of the heart. The fact that, in addition to well known effects of anthracyclines, also new drugs that target molecular pathways implicated in cell death and growth can be cardiotoxic further supports our hypothesis. Understanding the role of resident and extracardiac progenitors in the pathogenesis of cardiomyopathies of different etiology will provide not only a better comprehension of cardiac homeostasis but will also open new avenues for therapeutic interventions. The progress toward effective myocardial regeneration based on exploiting the self-renewal potential of the myocardium and the systemic pool of cardiogenic cells should advance the likelihood of efficient cardioprotection and restoration of cardiac function.
Export Options
About this article
Cite this article as:
Monia Savi , Federico Quaini , Antonella De Angelis , Francesco Rossi , Eugenio Quaini , Fancesca Re , Costanza Annamaria Lagrasta , Pietro Rossetti , Federica Galaverna , Francesca Ferraro , Konrad Urbanek , Lucia Prezioso , Andrea Gervasi , Bruno Lorusso , Stefano Cavalli , Angela Falco , Denise Madeddu , Gallia Graiani and Caterina Frati , Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors, Current Drug Targets 2015; 16 (8) . https://dx.doi.org/10.2174/1389450116666150126105002
DOI https://dx.doi.org/10.2174/1389450116666150126105002 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Current Topics in Pharmacogenomics)
Recent Patents on Biotechnology Protein O-GlcNAcylation: A Critical Regulator of the Cellular Response to Stress
Current Signal Transduction Therapy Electrocardiographic and Cardiac Autonomic Indices - Implications of Sex-Specific Risk Stratification in Women After Acute Myocardial Infarction
Current Pharmaceutical Design The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Current Pharmaceutical Design Gene-Wide Approach: New Frontiers in Cardiovascular Genetic Epidemiology
Current Hypertension Reviews Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target
Current Molecular Medicine The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction
CNS & Neurological Disorders - Drug Targets Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets The Role of Myocardial Collagen Network in Hypertensive Heart Disease
Current Hypertension Reviews Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Protein & Peptide Letters Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry Relaxin, Insulin and Diabetes: An Intriguing Connection
Current Diabetes Reviews Cell Penetrating Peptide Delivery of Splice Directing Oligonucleotides as a Treatment for Duchenne Muscular Dystrophy
Current Pharmaceutical Design Exploring the Role of Gene Therapy for Neurological Disorders
Current Gene Therapy Beneficial Extracardiac Effects of Cardiovascular Medications
Current Cardiology Reviews